Mark Spencer has joined CliniSys as Senior Vice President of Global Strategy. With 25-years’ experience in the life sciences and healthcare IT industry, Spencer will be charged with driving growth globally.
As the world looks to improve public health now and after the pandemic, Spencer will work closely with the senior leadership team to realise CliniSys’ vision to support its customers both inside and beyond the boundaries of the clinical laboratory to embrace a new wave of community laboratories and digital diagnostics in healthcare, toxicology, agriculture, water and environmental testing.
“CliniSys is at an exciting stage of growth after its recent M&A activity, priming it to deliver the integrated and holistic laboratory diagnostics that will drive the next wave of innovation in disease surveillance and tracking,” said Spencer. “That is why I am looking forward to returning to the company and driving the strategies that will accelerate our growth in key regions globally.”
“Mark brings with him a deep knowledge of healthcare and technology, and a wealth of experience leading an impressive list of successful business transformations in the sector,” said Michael Simpson, CEO of CliniSys.